“…Various studies have attempted to determine the most efficient protocol for patients with poor ovarian response, such as increasing the dose of gonadotrophins (13,14), the use of recombinant FSH (15), supplementation of growth hormone (16), and altered time and dose of administration of GnRH agonists (7,17). No convincing advantage for one protocol over another has been established to date (18).…”
“…Various studies have attempted to determine the most efficient protocol for patients with poor ovarian response, such as increasing the dose of gonadotrophins (13,14), the use of recombinant FSH (15), supplementation of growth hormone (16), and altered time and dose of administration of GnRH agonists (7,17). No convincing advantage for one protocol over another has been established to date (18).…”
“…Although two reports in the late 1980s suggested that high doses of gonadotropins (Ͼ300 IU per day) in poor responders enhanced follicular development (8) and reduced cycle cancellation rates (9), the preponderance of evidence does not support this approach (10 -13). Thus, although virtually all poor-responder protocols utilize high gonadotropin doses (typically 300 -450 IU per day), other tactics are usually also employed.…”
Section: Strategies For Treatment Of Poor Respondersmentioning
“…Some researchers have reported improved outcome [55,56]. According to most authors, the common initial dose for poor responders is at least 300 IU/day.…”
The ideal stimulation for these patients with diminished ovarian reserve remains a great challenge for the clinician, within the limits of our pharmaceutical quiver.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.